Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 16, 2025

Interscan Corporation Hosts Live Webinar on Navigating New EPA Ethylene Oxide Regulations for Healthcare Sterilization
Learn how new EPA rules impact ethylene oxide sterilization. Get expert insights on detection, monitoring, and compliance in this free 45-min webinar. CAMAS, WA, UNITED STATES, April 15, 2025 /EINPresswire.com/ -- April 15, 2025 – Camas, WA — Interscan …

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting
PRINCETON, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …

OncoC4 Selected to Present at the 2025 AACR Meeting's Showcase Session
Oral presentation will feature AI-081, a potentially best-in-class PD-1/VEGF bispecific antibody and ONC-841, a first-in-class anti-Siglec-10 antibody Initial clinical data for both AI-081 and ONC-841 in solid tumors expected 2H 2025 ROCKVILLE, Md., April …

Terra Balcanica Announces LIFE Offering
Vancouver, British Columbia, April 16, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB1) is pleased to announce that it intends to complete a non-brokered, listed issuer financing exemption private …

electroCore to Participate at the Planet MicroCap Showcase
ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet MicroCap Showcase taking place at the Paris …

Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types Continued progress of lead program, AKTX-101, for the treatment of solid tumors Platform technology to fuel …

ThreatQuotient Celebrates Record Year Marked by Major Customer and Partner Growth, Product Innovation, and Industry Recognition
Ashburn, VA. 16th April 2025 – ThreatQuotient, a leading innovator in threat intelligence platforms, has delivered exceptional growth and innovation over the past year. This growth has been fueled by increasing market demand for simplified security …

Dayforce to Announce First Quarter 2025 Financial Results on May 7th and Participate in Upcoming Investor Conferences
MINNEAPOLIS and TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Dayforce, Inc. (NYSE:DAY) (TSX:DAY), a global human capital management (HCM) leader that makes work life better, announced today the date for the release of its first quarter 2025 earnings and its …

Western Union Media Network Taps Magnite to Expand Advertising Capabilities
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, today announced an agreement with Western Union to support growth of the financial services company’s new Media Network business. In …

Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on Wednesday, April 23, …

Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, will present at the World Vaccine …

BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled
SUNRISE-PD evaluating the Company’s anti-inflammatory, insulin-sensitizing candidate bezisterim in patients with Parkinson’s disease who have not been treated with carbidopa/levodopa SUNRISE-PD is one of very few clinical trials for a Parkinson’s disease …

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™
MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering processes, is re-issuing an amended version of its April 10th, 2025, press …

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™
MONTRÉAL, 16 avr. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’ingénierie verte des procédés réédite une version modifiée de son communiqué du …

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results for the first quarter 2025 before …

Richtech Robotics Announces an Agreement to Purchase an Approximately 20,000 Square Foot Property to Expand Its Headquarters
New Las Vegas-based facility plans to increase manufacturing and assembly capacity by 400% and accommodate further integration of domestic supply chain Las Vegas, NV, April 16, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech …

American Tungsten Corp. Applauds U.S. Presidential Executive Order to Ensure National Security Through the Assessment of and Securing of Domestic Critical Minerals Supply Chains
Vancouver, BC, April 16, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) applauds U.S. President Donald Trump’s Executive Order seeking to foster a resilient national defense …

Avicanna Announces Revocation of Management Cease Trade Order
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …

Paladin to Defend Class Action
PERTH, Australia, April 16, 2025 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (Paladin) has today been served with a class action proceeding in the Supreme Court of Victoria. The class action alleges that Paladin made misleading …

Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and Australia for systemic lupus erythematosus CAMBRIDGE, …